ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107 | +25.9% | 4,018 | +65.4% | 0.00% | – |
| Q2 2023 | $85 | -9.6% | 2,429 | -34.6% | 0.00% | – |
| Q1 2023 | $94 | -26.0% | 3,713 | +18.0% | 0.00% | – |
| Q4 2022 | $127 | -99.9% | 3,147 | -17.4% | 0.00% | – |
| Q3 2022 | $125,000 | -6.0% | 3,811 | +0.2% | 0.00% | – |
| Q2 2022 | $133,000 | +52.9% | 3,804 | +97.4% | 0.00% | – |
| Q1 2022 | $87,000 | -5.4% | 1,927 | +37.3% | 0.00% | – |
| Q4 2021 | $92,000 | -94.5% | 1,403 | -94.8% | 0.00% | -100.0% |
| Q3 2021 | $1,675,000 | +701.4% | 26,847 | +961.1% | 0.00% | – |
| Q2 2021 | $209,000 | +10350.0% | 2,530 | +6737.8% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 37 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | -95.7% | 37 | -95.1% | 0.00% | – |
| Q4 2019 | $47,000 | – | 750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $20,836,128 | 14.83% |
| Aquilo Capital Management, LLC | 1,018,474 | $25,869,240 | 10.72% |
| Rokos Capital Management LLP | 1,675,921 | $41,537,702 | 3.07% |
| COMMODORE CAPITAL LP | 575,000 | $14,605,000 | 2.22% |
| Privium Fund Management B.V. | 259,036 | $6,579,514 | 2.21% |
| JOHNSON & JOHNSON | 247,598 | $6,288,989 | 2.05% |
| WEALTH EFFECTS LLC | 156,810 | $3,982,976 | 2.04% |
| M28 Capital Management LP | 67,400 | $1,711,960 | 1.94% |
| Evolutionary Tree Capital Management, LLC | 51,878 | $1,317,701 | 1.83% |
| Avidity Partners Management LP | 1,741,300 | $44,229,020 | 1.47% |